Emcure Pharmaceuticals Ltd.

₹1,839.1

-17.4 (-0.9%)

EMCURE Share Price

Pharmaceuticals & Biotechnology

As on July 3, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 34,913 Cr

P/E Ratio51.15

Dividend Yield0.02 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	1,842.4	Bearish
10-DMA	1,831.59	Bullish
20-DMA	1,780.36	Bullish
50-DMA	1,724.65	Bullish
100-DMA	1,622.62	Bullish
200-DMA	1,512.21	Bullish

Historical Performance

1 Year

43.7%

3 Years

N/A

5 Years

N/A

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	78,960	66,583	59,858	58,554	60,564
Total Expenditure	64,271	54,285	48,046	45,255	48,244
Other Income	728	570	459	635	354
Operating Profit	15,416	12,867	12,271	13,934	12,674
Interest	1,758	2,371	2,136	1,760	1,981
Depreciation	3,841	3,124	2,601	2,449	3,233
Profit Before Tax	9,713	7,272	7,472	9,725	6,573
Consolidated Net Profit	6,813	4,982	5,320	6,622	3,921
Adjusted EPS	36	28	29	37	22

Compounded Sales Growth

10 Years:15.9

5 Years:9.4

3 Years:6.2

TTM:3.5

Compounded Profit Growth

10 Years:21.6

5 Years:52.1

3 Years:0.6

TTM:6.5

Stock Price CAGR

10 Years:N/A

5 Years:N/A

3 Years:N/A

TTM:46.9

Return on Equity

10 Years:30.9

5 Years:21.7

3 Years:29.4

last year:36

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	1,895	1,812	1,809	1,809	1,809
Total Reserves	42,448	27,566	23,054	17,908	20,804
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	8,119	13,771	9,046	8,684	8,829
Other Current Liabilities	5,483	8,548	7,122	6,490	9,719
Short Term Borrowings	4,736	9,472	11,320	10,846	12,527
Total Liabilities	81,217	77,094	65,734	59,474	66,591
Capital Work in Progress	1,241	1,323	4,035	3,098	2,216
Long Term Loans & Advances	1,607	1,436	1,143	1,117	2,193
Currents Investments	760	2,997	---	---	---
Short Term Loans and Advances	2,953	2,391	2,675	2,665	1,699
Total Current Assets	45,559	42,545	38,359	34,241	37,174
Total Assets	81,217	77,094	65,734	59,474	66,591
Adjusted Book Value	234	162	137	109	125

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 51.15, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 16.3%, indicating sustained price appreciation.
The stock carries a low beta of 0.5, suggesting lower volatility than the broader market.
In the last financial year, the company reported an EBITDA of ₹15416 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹78960 million, indicating a large and established business.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1479446.5

No. of Shares: 804 (Approx)

Performance:47.9%

P/L: ₹479446.5

NIFTY Performance: -4.7%

1 day Top Gainers